Strides Arcolab has received US Food and Drug Administration (US FDA) approval for Adenoscan Injection Generic. Astellas Pharma’s heart drug Adenoscan sales stood at $65 million per year. Teva pharma’s Adenoscan exclusivity has ended on March 23, 2014.
Adenoscan is used for diagnostic purposes as an adjunct to thallium-201 myocardial perfusion scintigraphy. Adenocard and generic adenosine products are labeled for use in paroxysmal supraventricular tachycardia.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
